期刊文献+

达英-35联合二甲双胍治疗PCOS疗效观察 被引量:3

下载PDF
导出
摘要 目的多囊卵巢综合征患者通过应用达英-35(CPA)联合二甲双胍治疗,降低高LH、高雄激素血症可降低患者的体重,改善高雄激素环境提高卵巢排卵功能。方法将存在高LH、高T的PCOS肥胖患者周期随机分为两组:A组直接应用CC/HMG/HCG促排卵治疗3周期;B组自月经周期第2天给予达英-351片/d(并指导合理饮食)21d3周期同时二甲双胍三餐后各500mg3周期后促排卵治疗方法同A组。观察两组体重指数、月经周期、基础体温、卵泡发育及内分泌变化。结果试验组月经周期、基础体温、卵泡发育及内分泌变化优于对照组(P<0.05)。结论达英-35联合二甲双胍降低LH、雄激素效果好,明显降低患者体重指数,改善患者的临床症状及体征,提高了促排卵治疗的成功率。
作者 韩美英 魏敏
出处 《中国实用医药》 2011年第29期158-159,共2页 China Practical Medicine
  • 相关文献

参考文献3

  • 1Dumesic DA,,Abbott DH,Padmanabhan V.Polycystic ovary syndrome and its developmental origins[].Reviews in Endocrine and Metabolic Disorders.2007
  • 2The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group.Revised2003consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[].Fertility and Sterility.2004
  • 3赵晓苗,李扬志,杨冬梓,谢梅青.多囊卵巢综合征发病机制的研究进展[J].中华妇产科杂志,2008,43(2):154-156. 被引量:10

二级参考文献29

  • 1Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab, 2007,3 : 103-111.
  • 2Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome : involvement of genetic and environmental factors. Int J Androl,2006 ,29 :278-285.
  • 3Waterworth DM, Bennett ST, Gharani N, et al. Linkage and association of insulin gene VNTR regadatory polymorphism with polycystic ovary syndrome. Lancet, 1997,349:986-990.
  • 4Urbanek M, Legro RS, Driscoll DA, et aL Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc Nail Acad Sci U S A, 1999, 96: 8573- 8578.
  • 5Diamanfi-Kandarakis E, Bartzis MI, Bergiele AT, et al. Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYPllalpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril,2000 ,73 :735-741.
  • 6Franks S, Gharani N, Gilling-Smith C. Polycysfic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis. J Steroid Biochem Mol Biol,1999 ,69 :269-272.
  • 7Gaasenbeek M, PoweU BL, Sovio U, et al. Large-scale analysis of the relationship between CYPllA promoter variation, polycystic ovarian syndrome, and serum testosterone J Clin Endocrinol Metab ,2004,89:2408-2413.
  • 8Michehnore K, Ong K, Mason S, et al. Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clin Endocrinol (Oxf), 2001,55:439-446.
  • 9Vankova M, Vrbikova J, Hill M, et al.Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Ann N Y Acad Sci ,2002,967:558-565.
  • 10Powell BL, Haddad L, Bennett A, et al. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat dement and polycystic ovary syndrome or related traits. J Clin Endocrinol Metab ,2005,90:2988-2993.

共引文献9

同被引文献26

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部